BM MSC can be efficiently delivered to the affected brain regions of PSP patients where they can exert their beneficial effects through different mechanisms including the secretion of neurotrophic factors.Here we propose a randomized , placebo-controlled , double-blind phase I clinical trial in patients affected by PSP with MSC delivered via intra-arterial injection .